Pharma Q3 Results Preview - Positive Attributes To Aid In Revenue Growth, Gross Margins: Axis Securities

We expect the pharma universe under our coverage to report healthy aggregate revenue/Ebitda/PAT growth of 7.4%/9.5%/9.1% YoY.

Axis Securities

10 Jan 2023, 02:02 PM IST

Colourful capsules arranged for photograph. (Source: pxhere.com)

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Pharma Q3 Results Preview - Positive Attributes To Aid In Revenue Growth, Gross Margins: Axis Securities

We expect the pharma universe under our coverage to report healthy aggregate revenue/Ebitda/PAT growth of 7.4%/9.5%/9.1% YoY.

Choose a plan